Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803

Journal of the National Cancer Institute

Volumn 104, Issue 22, 2012, Pages 1702-1711

  Meyerhardt, Jeffrey A ^a   Sato, Kaori ^a   Niedzwiecki, Donna ^b   Ye, Cynthia ^b   Saltz, Leonard B ^c   Mayer, Robert J ^a   Mowat, Rex B ^d   Whittom, Renaud ^e   Hantel, Alexander ^f   Benson, Al ^g   Wigler, Devin S ^a   Venook, Alan ^h   Fuchs, Charles S ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Toledo Community Hospital Oncology Program   (United States)

^e HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^f LOYOLA UNIVERSITY CHICAGO   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FLUOROURACIL; FOLINIC ACID; FRUCTOSE; IRINOTECAN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CARBOHYDRATE INTAKE; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GLYCEMIC LOAD; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; COLONIC NEOPLASMS; DIETARY CARBOHYDRATES; DIETARY SUCROSE; DISEASE-FREE SURVIVAL; ENERGY INTAKE; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; GLYCEMIC INDEX; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84870206585     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs399     Document Type: Article

References (61)

1. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001;131(11)(suppl):3109S-3120.S. (Pubitemid 33070788)
2. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc. 2001;60(1):91-106. (Pubitemid 32183103)
3. Giovannucci E. Diet, body weight, and colorectal cancer: a summary of the epidemiologic evidence. J Womens Health (Larchmt). 2003;12(2):173-182. (Pubitemid 36546762)
4. Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2533-2547. (Pubitemid 351196307)
5. Samad AK, Taylor RS, Marshall T, et al. A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis. 2005;7(3):204-13. (Pubitemid 40637417)
6. Larsson SC, Rafter J, Holmberg L, et al. Red meat consumption and risk of cancers of the proximal colon, distal colon and rectum: the Swedish Mammography Cohort. Int J Cancer. 2005;113(5):829-834. (Pubitemid 40109508)
7. Kaaks R, Toniolo P, Akhmedkhanov A, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst. 2000;92(19):1592-1600.
8. Wei EK, Ma J, Pollak MN, et al. A prospective study of C-peptide, insulin- like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2005;14(4):850-855. (Pubitemid 40478547)
9. Schoen RE, Tangen CM, Kuller LH, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst. 1999;91(13):1147-1154. (Pubitemid 29330553)
10. Ma J, Giovannucci E, Pollak M, et al. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst. 2004;96(7):546-553. (Pubitemid 38559579)
11. Wolever TM, Jenkins DJ. The use of the glycemic index in predicting the blood glucose response to mixed meals. Am J Clin Nutr. 1986;43(1):167-172. (Pubitemid 16099799)
12. Wolever TM, Jenkins DJ, Jenkins AL, et al. The glycemic index: methodology and clinical implications. Am J Clin Nutr. 1991;54(5):846-854.
13. Liu S, Manson JE, Stampfer MJ, et al. Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr. 2001;73(3):560-566. (Pubitemid 32176507)
14. Higginbotham S, Zhang ZF, Lee IM, et al. Dietary glycemic load and risk of colorectal cancer in the Women's Health Study. J Natl Cancer Inst. 2004;96(3):229-233. (Pubitemid 38263182)
15. Franceschi S, Dal Maso L, Augustin L, et al. Dietary glycemic load and colorectal cancer risk. Ann Oncol. 2001;12(2):173-178. (Pubitemid 32223863)
16. Gnagnarella P, Gandini S, La Vecchia C, et al. Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr. 2008;87(6):1793-1801. (Pubitemid 351872644)
17. Michaud DS, Fuchs CS, Liu S, et al. Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2005;14(1):138-147.
18. Larsson SC, Giovannucci E, Wolk A. Dietary carbohydrate, glycemic index, and glycemic load in relation to risk of colorectal cancer in women. Am J Epidemiol. 2007;165(3):256-261. (Pubitemid 46174749)
19. Strayer L, Jacobs DR, Jr., Schairer C, et al. Dietary carbohydrate, glycemic index, and glycemic load and the risk of colorectal cancer in the BCDDP cohort. Cancer Causes Control. 2007;18(8):853-863. (Pubitemid 47125117)
20. Weijenberg MP, Mullie PF, Brants HA, et al. Dietary glycemic load, glycemic index and colorectal cancer risk: results from the Netherlands Cohort Study. Int J Cancer. 2008;122(3):620-629. (Pubitemid 350308955)
21. Terry PD, Jain M, Miller AB, et al. Glycemic load, carbohydrate intake, and risk of colorectal cancer in women: a prospective cohort study. J Natl Cancer Inst. 2003;95(12):914-916. (Pubitemid 36833883)
22. Dignam JJ, Polite BN, Yothers G, et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst. 2006;98(22):1647-1654. (Pubitemid 44811647)
23. Haydon AM, Macinnis RJ, English DR, et al. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut. 2006;55(1):62-67. (Pubitemid 41820637)
24. Meyerhardt JA, Heseltine D, Niedzwiecki D, et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006;24(22):3535-3541. (Pubitemid 46630523)
25. Meyerhardt JA, Giovannucci EL, Ogino S, et al. Physical activity and male colorectal cancer survival. Arch Intern Med. 2009;169(22):2102-2108.
26. Meyerhardt JA, Giovannucci EL, Holmes MD, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006;24(22):3527-3534. (Pubitemid 46630522)
27. Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007;298(7):754-764. (Pubitemid 47263158)
28. Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol. 2008;26(25):4109-4115.
29. Greene FL. TNM staging for malignancies of the digestive tract: 2003 changes and beyond. Semin Surg Oncol. 2003;21(1):23-29. (Pubitemid 37127471)
30. Saltz LB, Niedzwiecki D, Hollis D, et al. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803. J Clin Oncol. 2007;25(23):3456-3461. (Pubitemid 47310883)
31. Zubrod C, Scheiderman M, Frei E, et al. Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis. 1960;11:7-33.
32. Willett WC, Reynolds RD, Cottrell-Hoehner S, et al. Validation of a semiquantitative food frequency questionnaire: comparison with a 1-year diet record. J Am Diet Assoc. 1987;87(1):43-47. (Pubitemid 17000788)
33. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122(1):51-65. (Pubitemid 15010435)
34. U.S. Department of Agriculture ARS. USDA Nutrient Database for Standard Reference, release 10. Nutrient Data Laboratory home page. http://www.nal.usda. gov/fnic/foodcomp. Accessed December 22, 2008.
35. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124(1):17-27. (Pubitemid 16095831)
36. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol. 1989;18(4):858-867. (Pubitemid 20030201)
37. Meyerhardt JA, Heseltine D, Campos H, et al. Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy. J Clin Oncol. 2005;23(33):8453-8460.
38. Oh K, Willett WC, Fuchs CS, et al. Glycemic index, glycemic load, and carbohydrate intake in relation to risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev. 2004;13(7):1192-1198. (Pubitemid 38917908)
39. Hu FB, Stampfer MJ, Rimm E, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol. 1999;149(6): 531-540. (Pubitemid 29130020)
40. Cox D. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
41. Hu FB, Rimm EB, Stampfer MJ, et al. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000;72(4):912-921.
42. Michaud DS, Skinner HG, Wu K, et al. Dietary patterns and pancreatic cancer risk in men and women. J Natl Cancer Inst. 2005;97(7):518-524. (Pubitemid 40590433)
43. van Dam RM, Rimm EB, Willett WC, et al. Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med. 2002;136(3):201-209. (Pubitemid 34118120)
44. Kabat GC, Shikany JM, Beresford SA, et al. Dietary carbohydrate, glycemic index, and glycemic load in relation to colorectal cancer risk in the Women's Health Initiative. Cancer Causes Control. 2008;19(10): 1291-1298.
45. Li HL, Yang G, Shu XO, et al. Dietary glycemic load and risk of colorectal cancer in Chinese women. Am J Clin Nutr. 2011;93(1):101-107.
46. McCarl M, Harnack L, Limburg PJ, et al. Incidence of colorectal cancer in relation to glycemic index and load in a cohort of women. Cancer Epidemiol Biomarkers Prev. 2006;15(5):892-896. (Pubitemid 43823514)
47. Mulholland HG, Murray LJ, Cardwell CR, et al. Glycemic index, glycemic load, and risk of digestive tract neoplasms: a systematic review and metaanalysis. Am J Clin Nutr. 2009;89(2):568-576.
48. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am. 2002;31(4):925-943. (Pubitemid 35403506)
49. Meyerhardt JA, Ma J, Courneya KS. Energetics in colorectal and prostate cancer. J Clin Oncol. 2010;28(26):4066-4073.
50. Vrieling A, Kampman E. The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr. 2010;92(3):471-490.
51. Mendez MA, Covas MI, Marrugat J, et al. Glycemic load, glycemic index, and body mass index in Spanish adults. Am J Clin Nutr 2009;89(1):316-322.
52. Mirza NM, Klein CJ, Palmer MG, et al. Effects of high and low glycemic load meals on energy intake, satiety and hunger in obese Hispanic- American youth. Int J Pediatr Obes. 2011;6(2-2):e523-e531.
53. Micha R, Nelson M. Glycemic index and glycemic load used in combination to characterize metabolic responses of mixed meals in healthy lean young adults. J Am Coll Nutr. 2011;30(2):113-125.
54. Barkoukis H, Marchetti CM, Nolan B, et al. A high glycemic meal suppresses the postprandial leptin response in normal healthy adults. Ann Nutr Metab. 2007;51(6):512-518. (Pubitemid 351315916)
55. Pollak MN, Perdue JF, Margolese RG, et al. Presence of somatomedin receptors on primary human breast and colon carcinomas. Cancer Lett. 1987;38(1-2):223-30. (Pubitemid 18005853)
56. Watkins L, Lewis L, Levine A. Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. Int J Cancer. 1990;45:372-375. (Pubitemid 20061396)
57. Koenuma M, Yamori T, Tsuruo T. Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res. 1989;80(1):51-58. (Pubitemid 20027198)
58. Bjork J, Nilsson J, Hultcrantz R, et al. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol. 1993;28(10):879-884. (Pubitemid 23294761)
59. Brito JO, Ponciano K, Figueroa D, et al. Parasympathetic dysfunction is associated with insulin resistance in fructose-fed female rats. Braz J Med Biol Res. 2008;41(9):804-808.
60. Wu T, Giovannucci E, Pischon T, et al. Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in US women. Am J Clin Nutr. 2004;80(4):1043-1049.
61. Wolpin BM, Meyerhardt JA, Chan AT, et al. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol. 2009;27(2):176-185.